Abstract
Despite recent progress in surgical procedures and therapeutic modalities, the outcomes of treatment for pancreas cancer are still not satisfactory. Chemotherapy can provide symptom relief in some patients, but its impact on survival has been modest and it can lead to unacceptable levels of toxicity. To develop novel and potentially less toxic forms of cancer therapy, molecular targeting therapy is being based initially on the knowledge of cellular signal transduction. The new approaches in treatment have originated from biochemical studies in combination with recent technology to block the progress of carcinogenesis or invasion. As one of the most successful of such agents, an antibody or antagonist against the receptor of epidermal growth factor or vascular endothelial growth factor has been proven in carcinoma treatment, and recent steps have been taken to apply this type of treatment to pancreas cancer. However, there are still serious problems for these receptor-associated signaling blockers; namely, the antibody or antagonist has no efficacy if the target cells grow independently of the receptor-related signaling. On the other hands, extra-cellular signal-regulated kinase (ERK) is well known to represent a convergent point for the intracellular signaling pathways in whole cancer cells. In the present, by reviewing our recent studies that evaluate the usefulness of the vitamin K3 (menadione, 2-methyl-1,4-naphthoquinone; VK3)-induced growth inhibitory effect through ERK pathway, this novel approach to cancer therapy and its potential in future clinical applications will be highlighted.
Keywords: Vitamin K3 (menadione), extracellular signal-regulated protein kinase (ERK), molecular targeting therapy, pancreas cancer, drug delivery system, endoscopic ultrasound (EUS)-guided fine-needle injection (FNI)
Anti-Cancer Agents in Medicinal Chemistry
Title: A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy
Volume: 9 Issue: 8
Author(s): Shinji Osada and Kazuhiro Yoshida
Affiliation:
Keywords: Vitamin K3 (menadione), extracellular signal-regulated protein kinase (ERK), molecular targeting therapy, pancreas cancer, drug delivery system, endoscopic ultrasound (EUS)-guided fine-needle injection (FNI)
Abstract: Despite recent progress in surgical procedures and therapeutic modalities, the outcomes of treatment for pancreas cancer are still not satisfactory. Chemotherapy can provide symptom relief in some patients, but its impact on survival has been modest and it can lead to unacceptable levels of toxicity. To develop novel and potentially less toxic forms of cancer therapy, molecular targeting therapy is being based initially on the knowledge of cellular signal transduction. The new approaches in treatment have originated from biochemical studies in combination with recent technology to block the progress of carcinogenesis or invasion. As one of the most successful of such agents, an antibody or antagonist against the receptor of epidermal growth factor or vascular endothelial growth factor has been proven in carcinoma treatment, and recent steps have been taken to apply this type of treatment to pancreas cancer. However, there are still serious problems for these receptor-associated signaling blockers; namely, the antibody or antagonist has no efficacy if the target cells grow independently of the receptor-related signaling. On the other hands, extra-cellular signal-regulated kinase (ERK) is well known to represent a convergent point for the intracellular signaling pathways in whole cancer cells. In the present, by reviewing our recent studies that evaluate the usefulness of the vitamin K3 (menadione, 2-methyl-1,4-naphthoquinone; VK3)-induced growth inhibitory effect through ERK pathway, this novel approach to cancer therapy and its potential in future clinical applications will be highlighted.
Export Options
About this article
Cite this article as:
Osada Shinji and Yoshida Kazuhiro, A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy, Anti-Cancer Agents in Medicinal Chemistry 2009; 9 (8) . https://dx.doi.org/10.2174/187152009789124691
DOI https://dx.doi.org/10.2174/187152009789124691 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Transcription Factors by Heterotrimeric G Proteins
Current Molecular Pharmacology Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Current Medicinal Chemistry Histopathological Determinants of Tumor Resistance: A Special Look to the Immunohistochemical Expression of Carbonic Anhydrase IX in Human Cancers
Current Medicinal Chemistry Bcl-2 Family Proteins as Therapeutic Targets
Current Pharmaceutical Design Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation- Mediated Sensory and Motor Dysfunction in A Rat Model of Compression Spinal Cord Injury
Current Molecular Pharmacology Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Radiation Therapy in the Early 21st Century: Technological Advances
Current Cancer Therapy Reviews New Cancer Chemotherapy Agents: Inhibitors of DNA Polymerase
Current Drug Therapy Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry The Hedgehog Knows Many Tricks
Current Drug Targets Functional Genomics: New Insights into the Function of Low Levels of Gene Expression in Stem Cells
Current Genomics Self-care improvement after a pharmaceutical intervention in elderly type 2 diabetic patients
Current Diabetes Reviews Bestatin as an Experimental Tool in Mammals
Current Drug Metabolism Editorial: Role of Cancer Stem Cells in Common Gastrointestinal Cancers: From Pathogenesis to Therapeutic Targets
Current Stem Cell Research & Therapy Apoptosis-Inducing Activity and Antiproliferative Effect of Gossypin on PC-3 Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Pharmacokinetic Profiles of Anticancer Herbal Medicines in Humans and the Clinical Implications
Current Medicinal Chemistry Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Weekly Low-doses with Prolonged Infusion of Gemcitabine /Cisplatin for Multi-treated Metastatic Breast Cancer Patients
Current Cancer Therapy Reviews The Mechanism of Calcitriol in Cancer Prevention and Treatment
Current Medicinal Chemistry